Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine for multimodal analgesia in anorectal surgery
ChiCTR2600117519Phase 4Not yet recruiting
- Sponsor
- The First People's Hospital of Wenling
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in hemorrhoid, anal fissure, anal fistula and 2 more (6 arms), sponsored by The First People's Hospital of Wenling. Primary endpoints: Pain score and Postoperative complications. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
hemorrhoidanal fissureanal fistulaperianal abscesspostoperative pain
Beyond the preview
Go deeper on ChiCTR2600117519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600117519.